Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Terminated1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05583916Not ApplicableUnknown
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
Lung CancerSurgery
PrincipalinvestigatorStart date: 2022-09-07
NCT04638582Phase 2Terminated
Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)
Lung Cancer, Nonsmall Cell
PrincipalinvestigatorStart date: 2022-08-28
NCT04409925Phase 1Completed
DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)
COVID-19 Infection
PrincipalinvestigatorStart date: 2020-12-25

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

McGill University Health Centre/Research Institute of the McGill University Health Centre

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05583916Not ApplicablePrincipalInvestigator

Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery

Lung CancerSurgery
Unknown
NCT04638582Phase 2PrincipalInvestigator

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer, Nonsmall Cell
Terminated
NCT04409925Phase 1PrincipalInvestigator

DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)

COVID-19 Infection
Completed

All 3 trials loaded